Adiponectin improves insulin sensitivity and may have anti-atherogenic and anti-inflammatory properties, and low plasma adiponectin levels have been shown to predict type 2 diabetes and coronary heart disease in humans. This evidence concerns the gene ADIPOQ and type 2 diabetes mellitus.